Is a complete PODD research report available?

No complete published report is available for Insulet Corporation (PODD) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

PODD Stock Analysis, Forecast & Valuation

Market cap	11.8B
Revenue (ttm)	2.9B
Net income (ttm)	302.8M
EPS (ttm)	$4.29
Shares out	69.3M
P/E (trailing)	39.8x
P/E (forward)	25.5x
Volume	1,126,102
Beta	1.11

Price target	$236	+38.0%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PODD indicators

Market & fundamental data

Available fields

273

Groups with data

Currency

USD

Showing 273 of 273 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001145197
Company name	Insulet Corporation
Country	United States
Country code	US
Cusip	45784P101
Employees	5,400
Employees Change	1,500%
Employees Change Percent	38.46
Enterprise value	$12.4B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Medical Devices
Industry PE	40.96
Industry PE Fwd	19.8
IPO Date	2007-05-15
Isin	US45784P1012
Last refreshed	2026-07-30
Market cap	$11.8B
Market cap category	Large-Cap
Price	$171
Price currency	USD
Rev Per Employee	537,185.19x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	3841
Symbol	PODD
Website	https://www.insulet.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.56%
EV Earnings	40.79x
EV Sales Forward	3.58x
EV/EBIT	24.35x
EV/EBITDA	20.51x
EV/FCF	29.71x
EV/Sales	4.26x
FCF yield	3.52%
Forward P/E	25.46x
P/B ratio	9.07x
P/E ratio	39.78x
P/S ratio	4.07x
PE Ratio10 Y	2,027.35x
PE Ratio3 Y	84.39x
PE Ratio5 Y	2,517.56x
PEG ratio	1.15x
PS Forward	3.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.48%
EBITDA Margin	20.76%
FCF margin	14.33%
Gross margin	71.01%
Gross Profit	$2.1B
Gross Profit Growth	33.06%
Gross Profit Growth Q	29.31%
Gross Profit Growth3 Y	32.06%
Gross Profit Growth5 Y	27.02%
Net Income	$302.8M
Net Income Growth	-24.71%
Net Income Growth Q	157.35%
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Net Income Growth3 Y	696.16%
Net Income Growth5 Y	102.47%
Pretax Margin	13.94%
Profit Margin	10.44%
Profit Per Employee	$56,074
Profitable Quarters	$14
Profitable Years	8
ROA	9.75
Roa5y	5.52
ROCE	22.06
ROE	23
Roe5y	19.81
ROIC	20.87
Roic5y	13.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.16%
Cagr15y	15.46%
Cagr1y	-41.64%
Cagr3y	-15.27%
Cagr5y	-8.94%
EPS Growth	-22.69
EPS Growth Q	159
EPS Growth Quarters	3
EPS Growth Years	0
EPS Growth3 Y	691.9
EPS Growth5 Y	102.2
FCF Growth	42.71%
FCF Growth Q	73.79%
FCF Growth3 Y	220.73%
OCF Growth	52.39%
OCF Growth Q	78.37%
OCF Growth3 Y	66.9%
OCF Growth5 Y	63.81%
Revenue Growth	31.92x
Revenue Growth Q	33.87x
Revenue Growth Quarters	42x
Revenue Growth Years	11x
Revenue Growth3 Y	28.47x
Revenue Growth5 Y	24.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.89
Assets	$3B
Cash	$480.4M
Current Assets	$1.7B
Current Liabilities	$687.5M
Debt	$1B
Debt EBITDA	$1.68
Debt Equity	$0.78
Debt FCF	$2.44
Equity	$1.3B
Interest Coverage	7.82
Liabilities	$1.7B
Long Term Assets	$1.3B
Long Term Liabilities	$997.1M
Net Cash	$-533.6M
Net Cash By Market Cap	$-4.52
Net Debt EBITDA	$0.89
Net Debt Equity	$0.41
Net Debt FCF	$1.28
Tangible Book Value	$1.1B
Tangible Book Value Per Share	$16.4
WACC	9.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.49
Inventory Turnover	1.86
Net Working Capital	$560.2M
Quick ratio	1.49
Working Capital	$1B
Working Capital Turnover	$2.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	4.15%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	387.35%
1Y total return	-41.62%
200-day SMA	233.6
3Y total return	-39.18%
50-day SMA	154.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-37.39%
All Time High	354.9
All Time High Change	-51.92%
All Time High Date	2025-11-20
All Time Low	2.57
All Time Low Change	6,538.91%
All Time Low Date	2009-03-09
ATR	6.39
Beta	1.11
Beta1y	-0.14
Beta2y	0.45
Ch YTD	-39.97
High	171.8
High52	354.9
High52 Date	2025-11-20
High52ch	-51.92%
Low	165.3
Low52	138.8
Low52 Date	2026-06-22
Low52ch	22.93%
Ma50ch	10.19%
Premarket Change Percent	0.56
Premarket Price	$168
Premarket Volume	22,998
Price vs 200-day SMA	-26.97%
RSI	62.13
RSI Monthly	39.11
RSI Weekly	36.78
Sharpe ratio	-1.24x
Sortino ratio	-1.47
Total Return	4.15%
Tr YTD	-39.97
Tr15y	763.9%
Tr1m	7.82%
Tr1w	7.36%
Tr3m	-6.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	25
Analyst Count Top	9
Analyst Price Target Top	$260
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$1.44
Earnings EPS Estimate Growth	23.08
Earnings Revenue Estimate	787,629,752x
Earnings Revenue Estimate Growth	21.34x
Operating Income	$507.1M
Operating Income Growth	48.8
Operating Income Growth Q	37.5
Operating Income Growth3 Y	81.15
Operating Income Growth5 Y	53.09
Operating margin	17.48
Price target	$236
Price Target Change	$38.05
Price Target Change Top	$52.24

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	68,984,037%
Float Percent	99.59%
Net Borrowing	-986,100,000
Shares Insiders	0.32%
Shares Institutions	103.57%
Shares Out	69,264,674
Shares Qo Q	-0.66%
Shares Yo Y	-4.16%
Short Float	6.73%
Short Ratio	3.07
Short Shares	6.71

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$349.9M
Adjusted OCF	553,500,000
Average Volume	1,295,491.3x
Bv Per Share	18.81
CAPEX	$-203.6M
Ch10y	387.3
Ch15y	763.9
Ch1m	7.82
Ch1w	7.36
Ch1y	-41.62
Ch3m	-6.7
Ch3y	-39.18
Ch5y	-37.39
Ch6m	-33.92
Change	1.88%
Change From Open	2.46
Close	167.5
Days Gap	-0.57
Depreciation Amortization	94,900,000
Dollar Volume	192,135,523.2
Earnings Date	2026-08-05
Earnings Time	bmo
EBIT	$507.2M
EBITDA	$602.1M
EPS	$4.29
F Score	7
FCF	$415.7M
FCF EV Yield	3.37x
FCF Per Share	$6
Financing CF	-1,192,900,000
Fiscal Year End	December
Founded	2,000
Goodwill	51,600,000
Graham Number	42.60366
Graham Upside	-75.03
Income Tax	$101.6M
Investing CF	-234,800,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-18
Lynch Fair Value	$107
Lynch Upside	-37.15
Ma150	206.1
Ma150ch	-17.23%
Ma20	162.3
Ma20ch	5.12%
Net CF	-802,700,000
Next Earnings Date	2026-08-05
Open	166.5
Optionable	Yes
P FCF Ratio	28.43
P FCF Ratio SBC	33.78
P OCF Ratio	19.08
P OCF Ratio SBC	21.35
Position In Range	82.24
Ppne	830,400,000
Pre Close	167.5
Price Date	2026-07-29
Price EBITDA	$19.63
Ptbv Ratio	10.4
Relative Volume	0.87x
Revenue	2,900,800,000x
SBC By Revenue	2.27x
Share Based Comp	65,800,000
Tax By Revenue	3.5x
Tax Rate	25.12%
Tr6m	-33.92%
Us State	Massachusetts
Volume	1,126,102
Z Score	9.44

Insulet Corporation (PODD)

Coverage state: Market snapshot only — no published research

Generate the first PODD analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PODD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PODD indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PODD

Frequently asked questions